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intracardiac repair.5,7,10 Cumulative results, however,
were mostly unsatisfactory in terms of either morbidity/
mortality or function.4-7
Recently, 1-stage complete unifocalization, through
both a midline and a clamshell approach, has been
achieved regardless of true pulmonary arterial anatomy.
S urgery for pulmonary atresia with ventricular septaldefect and major aortopulmonary collateral arteries
(PA, VSD, and MAPCAs) has markedly evolved in the
past decade. Traditionally, palliations promoting pul-
monary arterial growth1-3 or staged unifocalizations,4-9
or both were performed in preparation for subsequent
Background: Predicting postrepair right ventricular/left ventricular pres-
sure ratio has prognostic relevance for patients undergoing total repair
of pulmonary atresia, ventricular septal defect, and major aortopul-
monary collateral arteries. To this purpose, we currently rely on 2 novel
parameters: (1) preoperative total neopulmonary arterial index and (2)
mean pulmonary artery pressure changes during an intraoperative flow
study. Methods: Since January 1994, 15 consecutive patients (aged 64 ±
54 months) with pulmonary atresia, ventricular septal defect, and major
aortopulmonary collaterals were managed according to total neopul-
monary arterial index. Seven patients with hypoplastic pulmonary
arteries and a total neopulmonary arterial index less than 150 mm2/m2
underwent palliative right ventricular outflow tract reconstruction fol-
lowed by secondary 1-stage unifocalization and ventricular septal defect
closure. The other 8 patients with a preoperative index of more than 150
mm2/m2 underwent primary single-stage unifocalization and repair. The
ventricular septal defect was closed in all cases (reopened in 1). In 9,
such decision was based on an intraoperative flow study. Results:
Patients treated by right ventricular outflow tract reconstruction had a
significant increase of pulmonary artery index (P = .006) within 22 ± 6
months. Repair was successful in 14 cases (postrepair right ventricu-
lar/left ventricular pressure ratio = 0.47 ± 0.1). One hospital death
occurred as a result of pulmonary vascular obstructive disease, despite
a reassuring intraoperative flow study. Accuracy of this test in predict-
ing the postrepair mean pulmonary artery pressure was 89% (95% CI:
51%-99%). At follow-up (18 ± 12 months), all patients are free of symp-
toms, requiring no medications. Conclusion: The integrated approach to
total repair of pulmonary atresia, ventricular septal defect, and major
aortopulmonary collaterals by preoperative calculation of total neopul-
monary arterial index, right ventricular outflow tract reconstruction
(when required), and intraoperative flow study may lead to optimal
intermediate results. (J Thorac Cardiovasc Surg 1998;116:914-23)
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Concomitant intracardiac repair was possible in 80% to
100% of these cases.11-13 Single-stage unifocalization
and repair can most often be guided by either morpho-
logic preoperative criteria or intraoperative functional
data.14 Different treatments should be contemplated,
however, for patients with dominant, or exclusive,
MAPCAs as opposed to those with dominant, yet
severely hypoplastic, pulmonary arteries.15 We have
recently adopted both preoperative morphometric and
intraoperative physiologic criteria, in the framework of
a novel integrated approach.
Patients and methods
Between January 1994 and October 1997, 15 consecutive
patients with PA, VSD, and MAPCAs, aged 2 months to 13
years, underwent surgical treatment (Table I). Six (40%) were
less than 24 months of age, 6 (40%) were between 2 and 9
years of age, and 3 (20%) were between 9 and 13 years of
age. One patient had congenital heart block. All patients
underwent 2-dimensional echocardiography and hemody-
namic evaluation. 
Evaluation of MAPCAs and pulmonary arteries.
MAPCAs were first investigated by a descending aortogram,
followed by selective pressure measurements and angiogra-
phy. Native pulmonary arteries were visualized by retrograde
filling from a MAPCA injection or a pulmonary venous
wedge injection and by direct filling via a collateral or a pre-
vious shunt. Both MAPCAs and native pulmonary arteries
(when present) were classified for size, number of lung seg-
ments perfused, and areas of dual pulmonary blood supply.
True pulmonary arteries were measured immediately before
their bifurcation, according to Nakata and associates,16
whereas MAPCAs were measured distal to the stenoses con-
sidered surgically accessible, that is, within the lobar level.
The indexed cross-sectional areas of pulmonary arteries (PAI
= pulmonary artery index) and of MAPCAs (CAI = total
MAPCA index), as well as their sum, the total neopulmonary
artery index (TNPAI = CAI + PAI), were calculated for each
patient.14
Surgical policy. In our previous experience with PA and
VSD repair, we considered 150 mm2/m2 as the minimal PAI
acceptable for VSD closure.17 Similarly, in our more recent
experience with PA, VSD, and MAPCAs we elected a TNPAI
cutoff value of more than 150 mm2/m2 for complete repair.
Characteristics of MAPCAs and pulmonary artery morphology
are reported in Tables II, III, and IV.
Seven patients with TNPAI less than 150 mm2/m2 had very
small (<2.5 mm in size) to small (>2.5 mm in size, but PAI <
100 mm2/m2) pulmonary arteries (Table II) supplying, on
average, most pulmonary segments (Table III).
Eight patients with TNPAI greater than 150 mm2/m2 (Table
II) had absent pulmonary arteries (n = 2) or absent right pul-
monary artery (n = l) or small (n = 3) to medium-sized con-
fluent central pulmonary arteries (PAI > 100 mm2/m2, n = 2).
MAPCAs were the only source of pulmonary blood flow for
one (n = l) or both lungs (n = 2), or they supplied terminally
the majority of lung segments (n = 5) (Table III). 
Palliative right ventricular outflow tract reconstruction.
Patients with TNPAI < 150 mm2/m2 underwent reconstruc-
tion of the right ventricular outflow tract (RVOT) to promote
the growth of native pulmonary arteries by establishing for-
ward flow.
Cardiopulmonary bypass was instituted by aorta-bicaval can-
nulation and left atrial venting. While the patient was cooled
to 22°C, with the lungs ventilated and the heart ejecting and
without the collaterals being occluded, the pulmonary arteries
were thoroughly dissected free and distally clip-occluded.
RVOT reconstruction was accomplished by a small pul-
monary valved homograft in patients with very small pul-
monary arteries (n = 2) and by either prosthetic (polytetraflu-
oroethylene or Dacron) conduit (n = 3) or a short transannular
RVOT patch (n = 2) in patients with small pulmonary arteries
(n = 5). A short period of aortic crossclamping was used in all
to prevent air embolism through the ventriculotomy. 
Primary 1-stage complete unifocalization and repair.
Patients with a TNPAI greater than 150 mm2/m2 underwent 1-
stage midline complete unifocalization and repair.
After a generous flap of anterior pericardium had been
retrieved, the posterior mediastinum was dissected by means
of the transverse sinus approach,11 without the pleura being
opened. Collaterals anterior to the airway were followed
upstream to their aortic origin, whereas those posterior to the
airway, especially the left-sided ones, were dissected down-
stream from their aortic origin. Esophageal retraction was
often necessary for dissection of MAPCAs opposite the side
of the aortic arch. Once all collaterals were controlled, they
were snared and cardiopulmonary bypass was begun. While
the patient was being cooled to 30°C, the decompressed col-
laterals were further dissected distally, ligated at their origin,
transected, taken anteriorly to the airway (when required),
and unifocalized. All unifocalizations were performed by
favoring native tissue-to-tissue anastomoses and avoiding
prosthetic material in the periphery.11 In only 1 case, early in
our experience, was a polytetrafluoroethylene conduit used to
unifocalize a left lower lobe collateral with a long-segment
distal stenosis.
Table I. Patient population (n = 15)
Age
Mean ± SD 64 ± 54 mo
Median 58 mo
Range 2 mo–13 y
Sex, male/female 7:8
Weight (kg)
Mean ± SD 16.7 ± 8.4
Median 13.5
Range 4.2-34
Previous operations (No. of patients) 3
Central shunt 3
Epicardial pacemaker implantation 1
Shunt to a MAPCA 1
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In general, tissue-to-tissue anastomosis was achieved in 2
different ways: (1) end-to-side or side-to-side anastomosis of
a MAPCA to a native pulmonary artery or to other MAPCAs
(Figs l, C* and 2, C*) and (2) side-to-side posterior anasto-
mosis of a MAPCA to a native pulmonary artery or to another
MAPCA with anterior patch augmentation of untreated autol-
ogous pericardium (Fig 1, C**). Ligation was limited to
those collaterals perfusing areas of lung with dual blood sup-
ply, which were not considered useful for augmentation of
hypoplastic pulmonary arteries (Fig 1, C***).
During further cooling to 25°C, a valved homograft (either
pulmonary or aortic) was distally anastomosed to the pul-
monary confluence (Figs l, C and 2, C). The aorta was then
crossclamped and blood cardioplegic solution was adminis-
tered. The VSD was patch-closed through a longitudinal right
ventriculotomy. The atrial communication was closed in all but
1 case, in which a small 1-way atrial septal defect was created.
After the aortic crossclamp was released, the homograft was
proximally anastomosed to the right ventricle with a bovine
pericardium hood augmentation. A pressure line was placed
transatrially into the pulmonary arteries and kept in place for
48 hours. Thereafter, withdrawal pressure recordings and
blood samplings were performed to rule out residual intracar-
diac left-to-right shunting or RVOT obstruction, or both.
Secondary 1-stage complete unifocalization and repair.
Patients showing significant growth of central pulmonary
arteries after initial RVOT reconstruction (acquired TNPAI >
150 mm2/m2; n = 7) underwent secondary midline 1-stage
complete unifocalization and repair, based on the aforemen-
tioned criteria. The operative technique slightly differed,
however, in that the previously reconstructed RVOT, whether
by conduit or by outflow patch, was divided and its proximal
stump temporarily oversewn to avoid both systemic air
embolism and blood leakage into the operative field.
Intraoperative flow study. In 9 patients undergoing repair
(primary, 7; secondary, 2), an intraoperative compliance test
of the unifocalized pulmonary arterial tree was carried out
with the use of incremental transpulmonary flow challenges,
according to Reddy and associates.14 The flow study was rou-
tinely performed before aortic crossclamping, at a temperature
of 25°C, with beating heart and collapsed lungs. Care was
taken to push the left atrial vent well into the left ventricle to
avoid pulmonary artery pressure misreadings. The decision to
close the VSD was based on a mean pulmonary artery pres-
Table II. Patient demographics according to TNPAI
TNPAI < 150 (n = 7) TNPAI ‡ 150 (n = 8)
Mean ± SD Median Range Mean ± SD Median Range
Age (mo)
At RVOTR 35.1 ± 53.9 18 2-156 — — —
At repair* 57.3 ± 51.8 43 14-172 90.3 ± 42.9 84 21-154
Weight (kg)
At RVOTR 12.9 ± 9.8 11 4.2-34 — — —
At repair† 19.5 ± 13.3 16 6.7-48 20 ± 5.7 19 12-28
TNPAI, Total neopulmonary arterial index (mm2/m2); RVOTR, right ventricular outflow tract reconstruction.
*P value (t) = .2.
†P value (t) = .9.
Table III. Characteristics of pulmonary vascular supply
TNPAI < 150 TNPAI ‡ 150 
(n = 7) (n = 8)
No. of MAPCAs per patient
Mean ± SD 2.3 ± 0.9 3.6 ± 1.6
Median 2 4
Range 1-4 1-6
No. of lung segments 
supplied by MAPCAs
Mean ± SD 6.1 ± 1.1 11.4 ± 5.8
Median 7 9.5
Range 5-7 4-20
No. of lung segments 
supplied by PAs
Mean ± SD 13.9 ± 1.1 8.6 ± 5.8
Median 13 10
Range 13-15 0-16
TNPAI, Total neopulmonary arterial index (mm2/m2); MAPCAs, major aor-
topulmonary collateral arteries; PAs, pulmonary arteries.
Table IV. Indexed cross-sectional measurements
TNPAI < 150 TNPAI ‡ 150 
(n = 7) (n = 8)
CAI








Mean ± SD 120.2 ± 10 262.9 ± 77.7
Median 123 247
Range 100.6-130.2 151-364
TNPAI, Total neopulmonary arterial index (mm2/m2); CAI, total MAPCA
index (mm2/m2); MAPCA, major aortopulmonary collateral artery; PAI, pul-
monary artery index (mm2/m2).
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sure of less than or equal to 30 mm Hg with a transpulmonary
predicted cardiac index of 2.5 L/min per square meter.
Chromosome 22q11 microdeletion. All patients were
screened from both a phenotypic and genotypic viewpoint.
Chromosome 22q11 microdeletion, detected by fluorescent
in situ hybridization, was present in 4 patients (27%). Its
occurrence did not relate to any peculiar anatomic phenotype,
neither regarding pulmonary vascular supply (characteristics
of pulmonary arteries, number of MAPCAs, TNPAI at pre-
Fig 1. Surgical technique for 1-stage unifocalization in the
presence of native pulmonary arteries. A, Anatomic features
of native pulmonary arteries (PAs) and major aortopulmonary
collateral arteries (c0, anastomotic-type; c1, bifurcated termi-
nal-type; c2, terminal type). B, Scheme of unifocalization: c0,
c1, and c2 are closed with double pledget-supported sutures at
their aortic origin; c0 is transected and its pulmonary side is
oversewn; c1 and c2 are transected and longitudinally opened;
PAs are longitudinally opened. C, Final result (*tissue-to-tis-
sue anastomosis; **posterior tissue–to–tissue anastomosis
with anterior patch augmentation; ***suture ligation; pp,
autologous pericardial patch; h, homograft).
Fig 2. Surgical technique for 1-stage unifocalization in the
absence of native pulmonary arteries. A, Anatomic features
of MAPCAs (c0 and c1, terminal-type; c2, trifurcated termi-
nal-type). B, Scheme of unifocalization: c0, c1, and c2 are
closed with double pledget-supported sutures at their aortic
origin; c0 and all 3 branches of c2 are longitudinally opened;
left-sided branches of c2 are sutured side to side. C, Final
result (*tissue-to-tissue anastomosis; h, homograft).
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sentation) nor occurrence of a right aortic arch.18 There was
only a slight difference in the incidence of infundibular atre-
sia in these patients compared with those without 22q11 dele-
tion (50% vs 18%: P = .5). 
Follow-up. At discharge all patients underwent 2-dimen-
sional Doppler echocardiographic evaluation of the repair.
All have been followed-up by clinical check-up, echocardio-
gram, and, whenever possible, by elective cardiac catheteri-
zation (n = 11) and nuclear perfusion scan (n = 4). 
Data analysis. Descriptive statistics are expressed as mean
± standard deviation (SD), median and range, or 95% confi-
dence intervals (CI). Student paired t test was performed with
the use of SPSS for Windows version 7.0 (SPSS Inc,
Chicago, Ill).
Results
RVOT reconstruction. All 7 patients who under-
went RVOT reconstruction had significant growth of
central pulmonary arteries, within 22 ± 6 months of the
palliation (median 24, range 12-30 months). The mean
PAI increased from 46 ± 26 mm2/m2 (median 48, range
16-89) to 194 ± 74 mm2/m2 (median 170, range 128-
337) (P = .006). The acquired TNPAI after the pallia-
tion always exceeded 150 mm2/m2 (Fig 3), allowing
secondary 1-stage complete unifocalization and repair.
Repair: Early results. All 15 patients underwent
primary (n = 8) or secondary (n = 7) total repair. In 14
cases the VSD closure was successful and correlated
with a favorable postoperative right ventricular/left
ventricular pressure ratio (pRV/pLV) (Table V). The
remaining patient, a 12.8-year-old girl with medium-
sized pulmonary arteries and 4 stenotic MAPCAs,
who underwent primary 1-stage unifocalization and
repair, postoperatively had a hypersystemic right ven-
tricle, despite a reassuring intraoperative pulmonary
flow study (a mean pulmonary artery pressure of 29
mm Hg with a cardiac index of 2.5 L/min per square
meter). The VSD was reopened and the child could be
weaned from cardiopulmonary bypass, but she died in
the early postoperative period. Postmortem lung
microscopy revealed diffuse pulmonary vascular
obstructive disease. This was the only failure of the
intraoperative flow study to ascertain the suitability for
ventricular septation. In the remaining 8 patients,
mean pulmonary artery pressures detected at the
steady state (48 hours after the operation) closely ap-
proximated the values measured during the flow study
(difference of means = –4% [95% CI: –20% to 11%];
P = .2), with a pRV/pLV ranging from 0.35 to 0.65
(Table VI). Therefore accuracy of this test in predicting
Fig 3. PAI and TNPAI evolution after RVOT reconstruction. Dotted line, cutoff value for complete repair (see text).
Table V. Operative data for total repair (n = 14)
Cardiopulmonary bypass time (min)




Mean 58 ± 12
Median 56
Range 43-82
pRV/pLV (end of bypass)
Mean 0.47 ± 0.1
Median 0.49
Range 0.3-0.65
pRV/pLV, Right ventricular/left ventricular pressure ratio.
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the postrepair mean pulmonary artery pressure was
89% (95% CI: 51%-99%).
All survivors had a smooth postoperative course.
There were a few minor complications, including tran-
sient dysfunction of the left hemidiaphragm (n = l), left
upper lobe bronchopneumonia (n = l), and prolonged
episodes of bronchospasm (n = 4). Mean and median
hospital stays were 11 ± 5 days and 10 days, respec-
tively (range 6-22 days). At discharge, all patients were
in stable sinus rhythm (n = 13) or had DDD mode pac-
ing (n = l). Echocardiography revealed absence of
residual intracardiac defects and good right ventricular
function in all. Bronchospasm persisted in 3. 
Chromosome 22q11 microdeletion. Chromosome
22q11 microdeletion did not influence the surgical treat-
ment of the disease, the genotype and the anatomic phe-
notype being completely unrelated in the reported series.18
Follow-up. Follow-up ranged from 6 to 36 months
with mean and median intervals of 18 ± 12 and 13.5
months, respectively. One patient underwent successful
reoperation 2 months after the initial operation for
acute endocarditis of the right ventricle–pulmonary
artery homograft (postoperative pRV/pLV = 0.3). The
patient with congenital heart block required endocar-
dial pacemaker implantation 6 months after the opera-
tion for dysfunction of old epicardial leads.
Eleven patients underwent routine follow-up cardiac
catheterization 6 to 23 months after the repair (mean 14
± 6, median 13 months) (Fig 4). One patient with a peak
right ventricular pressure of 53 mm Hg (pRV/pLV =
0.53) underwent successful stent placement into the right
pulmonary artery distal to a right upper lobe MAPCA
unifocalization 20 months after the operation. Eleven
months later, a right ventricular pressure of 35 mm Hg
was found by 2-dimensional Doppler echocardiography.
Another patient underwent successful bilateral balloon
dilatation of pulmonary arteries 11 months after the
operation, with a subsequent fall of pRV/pLV from 0.5
to 0.33. A third patient had a discrete stenosis at the
anastomotic site of a unifocalized right inferior lobe
MAPCA, a discrete stenosis of the origin of the left pul-
monary artery, and residual patency of a small anasto-
motic collateral. Thirteen months after the operation, this
patient underwent both successful balloon dilatation of
the stenoses and coil occlusion of the collateral, with a
reduction of pRV/pLV from 0.62 to 0.44. Seven of 8 sur-
vivors after intraoperative flow study, 11 ± 3 months
postoperatively (median 11.5, range 6-13 months),
underwent cardiac catheterization, which showed stable
or decreasing mean pulmonary artery pressures com-
pared with those recorded during flow study (difference
of means: –20% [95% CI: –43% to 4%]; P = .07) and
pRV/pLV values comparable with those measured 48
hours after the operation (difference of means: –16%
[95% CI: 40% to 8%]; P = .3) (Table VI). Four patients
also underwent nuclear perfusion scans 1 to 7 days after
follow-up cardiac catheterization. They all showed sym-
metrical distribution of pulmonary blood supply.
In March 1998, all survivors were in New York Heart
Association class I, without medications. Their mean
peak right ventricular pressures assessed by either car-
diac catheterization (n = 11) or 2-dimensional Doppler
echocardiography (n = 14) were 43 ± 11 mm Hg
(median 45, range 23-63) and 40 ± 7 mm Hg (median
40, range 30-60), respectively. On the whole, the most
persistent late symptoms were related to bron-
chospasm (up to 1 year after the operation in 2 cases).
Discussion
Since unifocalization was introduced,19 several
staged procedures have been advocated in preparation
for complete repair. However, no consensus has been
Table VI. Hemodynamic data of patients evaluated with the flow study
During flow study After 48 h postop Postop cardiac catheterization
Indexed Mean Mean Mean 
Age Previous TNPAI peak flow PAP VSD PAP pRV/ Interval PAP pRV/ Qp/
Pt. No. (mo) RVOTR (mm2/m2) (L/min) (mm Hg) status (mm Hg) pLV (mo) (mm Hg) pLV Qs
1 154 No 184 2.5 29 Reopened – – – – – –
2 14 Yes 214 2.86 20 Closed 22 0.65 13 24 0.44 1:1
3 84 No 151 2.5 24 Closed 25 0.6 13 17 0.35 1:1
4 118 No 355 2.65 18 Closed 18 0.5 12 14 0.25 1:1
5 71 No 236 2.68 22 Closed 21 0.5 11 20 0.33 1:1
6 21 No 365 2.6 30 Closed 26 0.41 10 22 0.62 1:1
7 84 No 234 2.5 25 Closed 25 0.5 6 24 0.5 1:1
8 58 No 319 2.5 27 Closed 23 0.35 8 19 0.42 1:1
9 38 Yes 152 2.85 27 Closed 25 0.45 Not performed
RVOTR, Right ventricular outflow tract reconstruction; TNPAI, total neopulmonary arterial index; PAP, pulmonary artery pressure; VSD, ventricular septal defect;
pRV/pLV, right ventricular/left ventricular pressure ratio; Qp/Qs, pulmonary/systemic flow ratio.
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reached for crucial issues, for example, treatment of
hypoplastic pulmonary arteries3,6,9 strategy of unifocal-
ization,5,9,20,21 source of blood supply to the unifocal-
ized pulmonary circulation,4-7,9 and criteria for
repair.5,7,10 Unfortunately, most of these multistage
approaches have been inadequate in terms of cumula-
tive morbidity and mortality, real potential for repair,
and functional results of the repair itself.4-7
One-stage total unifocalization, recently introduced
by Reddy, Liddicoat, and Hanley,11 has been accom-
plished with any kind of true pulmonary arterial anato-
my using either a midline11,13 or a clamshell12 approach.
Combined cardiac repair has been possible in 80% to
100% of cases.11-13 It is suggested that, the earlier in
infancy the unifocalization is performed, the better the
long-term results are, owing to prevention of both shear
stress lesions of MAPCAs and pulmonary vascular
obstructive disease in distinct lung segments.11,13,14
Our policy differed slightly from that of primary 1-
stage unifocalization in all cases. In fact, we considered
primary unifocalization unfeasible in the not so rare
cases (up to 73%) of severely hypoplastic pulmonary
arteries combined with MAPCAs perfusing only a
minor proportion of lung segments.22 This reflected 2
main concerns. First, hypoplasia of central pulmonary
arteries would not provide adequate support for anasto-
mosing transected isolated collaterals. Second, under-
developed peripheral arborization of lung segments
served by hypoplastic true pulmonary arteries would
lead to preferential flow into the unifocalized collater-
als, resulting in uneven pulmonary blood flow distribu-
tion. We preferred to treat such an anatomic arrange-
ment by first allowing forward flow into true
pulmonary arteries to promote both their central and
peripheral growth15,23 and subsequently undertaking
midline 1-stage unifocalization and cardiac repair.11,13
To sort patients for either preliminary RVOT recon-
struction or primary 1-stage unifocalization and repair,
based on our previous experience with PAI for repair of
complex PA and VSD,17 we arbitrarily referred to a
TNPAI cutoff value of less than 150 or more than 150
mm2/m2, respectively. In this series, a TNPAI less than
150 mm2/m2 always correlated with a preoperative PAI
less than 100 mm2/m2 (very small to small pulmonary
arteries) and with dominance of pulmonary arteries
versus MAPCAs with respect to number of lung seg-
ments supplied (13.9 ± 1.1 vs 8.6 ± 5.8).
All 7 patients undergoing RVOT reconstruction had a
significant development of true pulmonary arteries (Fig
3) and successfully underwent secondary 1-stage uni-
focalization and cardiac repair. The growth of native
pulmonary arteries facilitated the recognition of lung
segments with dual blood supply.4,15 Collaterals
involved in dual lung supply were usually ligated at
unifocalization. Because of the lesser occurrence of
MAPCAs in this subgroup of patients and the routine
ligation of those responsible for dual supply, unifocal-
ization during secondary procedures involved a lesser
Fig 4. Angiographic evidence of totally unifocalized pul-
monary arterial tree. A, Postoperative angiogram of case
depicted in Fig 1. B, Postoperative angiography of case de-
picted in Fig 2.
Table VII. Surgical management of MAPCAs
Primary repair Secondary repair 
(n = 8) (n = 7)
No. of MAPCAs per patient
Mean ± SD 3.6 ± 1.6 2.3 ± 0.9
Median 4 2
Range 1-6 1-4
No. of anastomoses per patient
Mean ± SD 3 ± 1.6 1.1 ± 0.4
Median 3 1
Range 1-5 1-2
No. of ligations per patient
Mean ± SD 0.6 ± 0.7 1.1 ± 1
Median 0.5 1
Range 0-2 0-3
MAPCAs, Major aortopulmonary collateral arteries.
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number of anastomoses than did primary procedures
(Table VII).
In our experience, the best indicator of suitability for
VSD closure at the time of 1-stage unifocalization and
repair was the intraoperative pulmonary flow study.14
Used in the more recent part of the series (n = 9), the
flow study proved reliable in all but the first case.
Postmortem revision of this case showed the presence
of variable degrees of diffuse pulmonary vascular dis-
ease. The ensuing pulmonary vasoreactivity was prob-
ably further compounded by recurrent postoperative
metabolic acidosis associated with hypoxemia (right-
to-left atrial shunting through an artificial 1-way atrial
septal defect) and postoperative bleeding.
Our early results with both primary and secondary 1-
stage complete unifocalization and repair of PA, VSD,
and MAPCAs are sound, with a 93% rate of both early
survival and successful complete repair (95% CI: 66%-
100%). RVOT reconstruction was needed by patients
with limited collateral-dependent pulmonary blood
flow, who thus had early cyanosis. On the other hand,
patients with predominant collateral-dependent pul-
monary blood flow were referred to us only later in life.
Eventually, patients with RVOT reconstruction under-
went repair earlier than those having primary repair
(Table II). On the whole, 1-stage unifocalization and
repair were done later in life in a greater proportion of
our patients than would be expected from current
trends toward early correction.11,13,14 The greatest risk
of a delayed approach is the occurrence of pulmonary
vascular obstructive disease, which is difficult to pre-
dict and quantify in PA, VSD, and MAPCAs owing to
multifocal pulmonary blood supply and progressive
development of collateral stenoses.19,24-26 On a specu-
lative ground, the finding of stenotic collaterals in older
patients does not necessarily mean that the distal pul-
monary vascular bed is “protected.” In fact, such ste-
noses might occur even after the development of pul-
monary vascular obstructive disease, as suggested by
the only death that occurred in this series.
Despite such a relatively late age at repair, at inter-
mediate follow-up all survivors have low right ventric-
ular pressure, generally balanced distribution of blood
flow, and low need for major interventional procedures
on the reconstructed pulmonary arteries. Interestingly,
the mean pulmonary artery pressure and/or the pRV/
pLV at follow-up cardiac catheterization compared
favorably with those recorded both during flow study
and 48 hours after the operation. Such data further cor-
roborate the adequacy of the flow study in discriminat-
ing suitability for repair and possibly support the thesis
of an improved lung condition once normal hemody-
namics is restored.
Finally, the occurrence of chromosome 22q11
microdeletion in cases of PA, VSD, and MAPCAs has
recently been reported in association with a peculiar
anatomic phenotype,27 with an implicit need for more
complex surgical procedures.28 Our analysis failed to
demonstrate a similar correlation, probably because of
the very limited number of patients.
Limitations of the study. First, the small number of
patients of this series does not allow meaningful statis-
tical analysis. Second, in consideration of the some-
what old average age of the patients at the time of uni-
focalization (with the related risk of fully developed
pulmonary vascular obstructive disease), the good
results achieved in this series might express a sponta-
neous selection of patients with “protected” pulmonary
circulation. Finally, the shortness of the follow-up
interval does not allow definitive conclusions on the
fate of pulmonary circulation of unifocalized patients. 
Conclusion
In conclusion, preoperative morphologic criteria
allow the identification of a subgroup of patients with
PA, VSD, and MAPCAs who are likely to benefit from
an intermediate palliative stage (RVOT reconstruction).
Both primary and secondary 1-stage complete unifo-
calization are easily accomplished in most cases.
Intraoperative assessment of the compliance of the uni-
focalized pulmonary vascular bed may lead to safe
evaluation of suitability for ventricular septation. All
the aforementioned steps, within the framework of an
“integrated approach,” may lead to optimal intermedi-
ate results of complete repair of PA, VSD, and
MAPCAs with low pRV/pLV.
We gratefully acknowledge the technical assistance of
Giuseppe Bolla and the skillful artwork of Emilio Ferretti, MD.
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Discussion
Dr Mohan Reddy (San Francisco, Calif). At the
University of California at San Francisco, since starting 1-
stage unifocalization in 1992, we now have nearly 100
patients. As our approach has evolved, our strategy has
changed a bit. PA with VSD and MAPCAs is a complex and
heterogenous lesion with regard to pulmonary vasculature,
and this necessitates a neutralization of surgical strategy. 
Currently we perform complete unifocalization and repair
in over two thirds of our patients; that includes closure of the
VSD. In the remaining third, about three quarters of these
patients have undergone complete unifocalization in 1 stage
and the VSD was left open, and in the last 50 or so patients
we have used exclusively the intraoperative flow study to
determine the feasibility of VSD closure. In the remaining
few patients, about 5% to 8% of the total population, we have
used staged unifocalization via thoracotomies. 
I have 3 relatively simple questions: In patients in whom
you created a right ventricle–pulmonary artery conduit, you
did not control the collaterals during the bypass. What pH
strategy have you used and did you encounter any neurologic
problems with this approach? 
Second, what is your approach currently to a neonate or a
young infant who is symptomatic or asymptomatic and when
would you like to operate on this patient? 
Finally, have you seen any transient liver dysfunction in the
postoperative period, which needs to be managed very
aggressively in terms of the glucose and potassium?
Dr Carotti. Thank you, Dr. Reddy, for your comments. Our
approach differs slightly from your policy in San Francisco.
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We know that in most cases you proceed with 1-stage unifo-
calization. We elect, instead, to stage the repair in patients with
severely hypoplastic pulmonary arteries and few collaterals
supplying a minor proportion of lung segments rather than
doing the 1-stage operation. In fact, we suspect that in patients
with “dominant” hypoplastic pulmonary arteries undergoing a
primary complete unifocalization there is a reasonable risk of
unsuitability for primary VSD closure. Furthermore, we be-
lieve that, after palliative RVOT reconstruction, there is also a
reasonable chance of insufficient growth of the true pul-
monary arteries owing to preferential runoff into unifocalized
collaterals. Conversely, by staging the repair, by first perform-
ing a palliative RVOT reconstruction, we believe that the true
pulmonary arteries can develop more consistently in size and
that, therefore, the overall probability of total repair at the time
of unifocalization is increased.
With respect to your first question concerning pH strategy,
we always used the a -stat strategy and never encountered any
neurologic problem. As a matter of fact, we always tried to
run very short periods of cardiopulmonary bypass, keeping
the temperature at about 22°C, and to perfuse the patient with
high flows, such as 150 up to 200 mL/kg per minute. 
With respect to the approach to a symptomatic infant, since
we started this protocol we have never had the opportunity to
operate on a neonate or young infant. However, we did oper-
ate on our patients as soon as the cardiologist referred them
to us. We would like very much to start doing the single-stage
operation in young infants. We know that you do so and Dr
Tchervenkov does so. We plan to operate on those patients
within the ages of 6 months to 1 year. 
We never observed any problems with liver dysfunction or,
more in general, multiorgan dysfunction. Actually, we had
only transient hemoglobinuria in the early postoperative
course in patients who underwent a very long run of car-
diopulmonary bypass during 1-stage approaches. On the other
hand, we did not have any other problem, as demonstrated by
the very short mean hospital stay.
Dr Christo I. Tchervenkov (Montreal, Quebec, Canada).
I would like to congratulate you on excellent results. You
have achieved repairability in over 90% of the patients,
which is significantly higher than the previously published
large studies with a multistage approach. We have also
evolved at the Montreal Children’s Hospital from a multi-
stage approach to currently the single-stage approach, and
we presented our results last year at the Association meeting
in Washington. My questions will focus on the PAI, and I
applaud your efforts to try to develop predictive criteria for
the feasibility of single-stage repair versus staged repair in
these patients. 
Our observation has been that the PAI in the patient with
tetralogy of Fallot as determined by preoperative angiogram
or echocardiography frequently underestimates the true size
of the pulmonary arteries because they are simply underfilled.
We have consistently found in the small patients that in
diminutive arteries, both in regular tetralogy and tetralogy
with PA of MAPCAs, that the diminutive arteries are fre-
quently 1 or 2 or perhaps 3 mm larger in diameter than the
preoperative prediction. 
Have you tried to correlate your preoperative assessment of
size and index to the intraoperative findings? Is it possible
that some patients who are over that cutoff point of 150
mm/m2 are subjected to the multistage approach and yet
could actually undergo the definitive operation?
Second, what would you do with a patient who has no true
pulmonary arteries and yet has an index less than 150 mm/m2?
What would you do with a patient who has an index of perhaps
120 and has no true pulmonary arteries that can be developed? 
Third, our technique in Montreal has differed slightly from
Frank Hanley’s technique in San Francisco. We perform cen-
tral dissection to get at the MAPCAs instead of the peripheral
approach by opening the pleura. We go straight down to the
aorta, particularly if it is a right descending aorta. It is actually
quite easy to get at the collaterals without having to open the
pleura at all. The second difference is that we do not hesitate to
ligate collaterals, small MAPCAs that supply 1 or 2 segments,
providing that the rest of the unifocalized arterial bed is ade-
quate, or MAPCAs that go to regions of dual blood supply.
Dr Carotti. Thank you, Dr. Tchervenkov, for your questions. 
With regard to the first question, in this small series we did
not find discrepancy between the measurements or the index
and the real dimension of pulmonary arteries. I would remind
you that the original paper by Dr Nakata and associates did
estimate the measure of the pulmonary arteries in patients
with cyanotic heart diseases with a low filling volume of the
pulmonary arteries. 
Actually, it is always difficult to give a cutoff value and to
decide what to do on the basis of it. I think that, on the two
opposite extremes of the spectrum of the disease, it is easier
to decide what kind of procedure to perform. However, it
becomes more difficult to do so as you approach the “cutoff
value” from each side. 
With respect to what to do with a patient with a TNPAI of
120, absent pulmonary arteries, and exclusive collaterals, we
have not faced this problem yet. I would go ahead with the sin-
gle-stage unifocalization and rely only on the intraoperative
flow study in order to decide whether to close the VSD or not. 
With respect to your question about the surgical technique,
we definitely liked your modifications of Dr Hanley’s
approach. Actually, we never open the pleural spaces, be-
cause we previously had trouble sometimes during the multi-
ple-stage approach through thoracotomies, facing severe pul-
monary hemorrhage after manipulation of the lung. At
present, we dissect the collaterals only by the transverse sinus
approach; furthermore, we retrieve the more distal ones by
incising the posterior pericardium and extending the dissec-
tion behind the left atrium. 
With respect to the issue of small or anastomotic collater-
als, we try to use all collaterals we can in cases of primary 1-
stage approach to either retrieve pulmonary segments or per-
form a distal pulmonary artery reconstruction. In cases of
secondary 1-stage repair we usually ligate the anastomotic
collaterals. It depends on one’s general policy.
